Medistep Healthcare Ltd Approves Financial Results for FY26 Amid Record Revenue Growth
Medistep Healthcare Limited announced the approval of its Standalone Audited Financial Results for the half year and year ended March 31, 2026. The Board of Directors formally considered and approved these results during a meeting held on May 30, 2026.The company also confirmed that the Statutory Auditor has issued an unmodified opinion on the Standalone Annual Audited Financial Results for the year ended on March 31, 2026, providing a true and fair view of the company's financial status.
Financial Performance Summary
The Standalone Financial Results demonstrate significant growth across key metrics. Total income for the year ended March 31, 2026, reached 7,085.36 Lakhs. This compares to 4,965.86 Lakhs in the previous year.Key figures from the Standalone Financial Results for the year ended March 31, 2026, are detailed below:
| Particulars | Year ended 31.03.2026 (Rs. In Lakhs) | Year ended 31.03.2024 (Rs. In Lakhs) |
|---|---|---|
| Revenue from operations | 7,083.10 | 4,965.48 |
| Other income | 2.26 | 0.37 |
| Total income | 7,085.36 | 4,965.86 |
| Total expenses | 6,285.83 | 4,412.09 |
| Net Profit/Loss after tax | 598.30 | 414.40 |
| Earnings per share (Basic & Diluted) | 4.68 | 4.01 |
Balance Sheet and Cash Flow Analysis
As of March 31, 2026, Medistep Healthcare Limited reported total equity and liabilities of 3,782.46 Lakhs, up from 1,735.22 Lakhs in the preceding year. Shareholders' funds increased notably, driven by Reserves and surplus, which stood at 2,361.51 Lakhs.On the asset side, the total reported assets reached 5,029.71 Lakhs, compared to 2,300.08 Lakhs a year earlier. The largest component of current assets was Trade receivables, recorded at 3,938.59 Lakhs.
In terms of cash generation, the company recorded a Net cash from operating activities of (1,947.74) Lakhs for the year ended March 31, 2026, before accounting for taxes paid. The net cash generated from financing activities reached 1,878.69 Lakhs, driven by proceeds from equity share issuance.
IPO Proceeds Utilization
The company provided a certificate detailing the utilization of IPO proceeds. As of March 31, 2026, the total IPO proceeds utilized amounted to INR 1,559.17 Lakhs. The initial total amount allotted was 1,609.92 Lakhs, leaving an unutilized amount of 50.75 Lakhs.The utilization breakdown by object is as follows:
| Object of the Issue | Amount allotted (Rs. In Lakhs) | Amount utilized till 31st March 2026 (Rs. In Lakhs) | Amount unutilized till 31st March 2026 (Rs. In Lakhs) |
|---|---|---|---|
| Capital Expenditure Requirement | 50.75 | - | 50.75 |
| Working Capital Requirement | 1,234.17 | 1,234.17 | - |
| General corporate purpose | 164.01 | 164.01 | - |
| Public issue related expenses | 160.99 | 160.99 | - |
| Total | 1,609.92 | 1,559.17 | 50.75 |
MEDISTEP Stock Price Movement
Medistep Healthcare Limited shares on Friday slipped by 5.26% to settle at ₹18.00, shedding ₹1.00 from the previous day's close. The stock saw trading activity on a volume of 6,000 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.